Cargando…

Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention

Psychiatric diseases, such as schizophrenia, bipolar disorder, autism spectrum disorder, and major depressive disorder, place a huge health burden on society. Cognitive impairment is one of the core characteristics of psychiatric disorders and a vital determinant of social function and disease recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yafen, Meng, Weicheng, Liu, Zhixin, An, Qunxing, Hu, Xingbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666407/ https://www.ncbi.nlm.nih.gov/pubmed/36406755 http://dx.doi.org/10.3389/fncel.2022.1046692

Ejemplares similares

Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population
por: Iqbal, Ghazala, et al.
Publicado: (2020)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: Zhang, Xianqing, et al.
Publicado: (2018)

Aerobic exercise, an effective prevention and treatment for mild cognitive impairment
por: Huang, Baiqing, et al.
Publicado: (2023)

A Review of the Application of Virtual Reality Technology in the Diagnosis and Treatment of Cognitive Impairment
por: Liu, Yao, et al.
Publicado: (2019)

Hippocampus Radiomic Biomarkers for the Diagnosis of Amnestic Mild Cognitive Impairment: A Machine Learning Method
por: Feng, Qi, et al.
Publicado: (2019)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022)

Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer’s disease: how and what to tell. A kickstart to an ethical discussion
por: Porteri, Corinna, et al.
Publicado: (2014)

Hippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric Disease
por: Sigurdsson, Torfi, et al.
Publicado: (2016)

Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke
por: Ling, Yi, et al.
Publicado: (2020)

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
por: Chen, Nai-Ching, et al.
Publicado: (2020)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Neuronal oscillations: early biomarkers of psychiatric disease?
por: Günther, Anne, et al.
Publicado: (2022)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease
por: Giuliani, Angelica, et al.
Publicado: (2021)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences
por: Moore, Elizabeth E., et al.
Publicado: (2020)

Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo
por: ZHAN, WENHUA, et al.
Publicado: (2015)

Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo
por: Zhan, Wenhua, et al.
Publicado: (2018)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease
por: Qu, Yi, et al.
Publicado: (2023)

Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment and Chronic Neurobehavioral Changes
por: Chen, Yanxing, et al.
Publicado: (2017)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2021)

Altered Functional Connectivity of the Basal Nucleus of Meynert in Subjective Cognitive Impairment, Early Mild Cognitive Impairment, and Late Mild Cognitive Impairment
por: Xu, Wenwen, et al.
Publicado: (2021)

Editorial: Innovative treatments for neuro-psychiatric diseases
por: Gozzo, Lucia, et al.
Publicado: (2023)

Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease
por: Yin, Ping, et al.
Publicado: (2019)

Targeting Cognitive Impairment in Multiple Sclerosis—The Road toward an Imaging-based Biomarker
por: Van Schependom, Jeroen, et al.
Publicado: (2017)

Speech biomarkers of risk factors for vascular dementia in people with mild cognitive impairment
por: Martínez-Nicolás, Israel, et al.
Publicado: (2022)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

Bibliometric analysis of acupuncture and moxibustion treatment for mild cognitive impairment
por: Yang, Wei, et al.
Publicado: (2023)

Aberrant Functional Connectivity and Structural Atrophy in Subcortical Vascular Cognitive Impairment: Relationship with Cognitive Impairments
por: Zhou, Xia, et al.
Publicado: (2016)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Feng, Feng, et al.
Publicado: (2018)

Mild Cognitive Impairment: Structural, Metabolical, and Neurophysiological Evidence of a Novel EEG Biomarker
por: Moretti, Davide Vito
Publicado: (2015)

Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia
por: Hussain, Basharat, et al.
Publicado: (2021)

Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
por: Samat, Nor A., et al.
Publicado: (2017)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Ling-Yun, et al.
Publicado: (2018)

A Novel Imaging Biomarker for Cerebral Small Vessel Disease Associated With Cognitive Impairment: The Deep-Medullary-Veins Score
por: Xu, Zhihua, et al.
Publicado: (2021)

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvg9vv1k0dsr43mded3cert3pn